CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

Clinical trial NCT06306612 · RECRUITING

Trial details

NCT number: NCT06306612
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2024-03-21
Primary completion: 2028-12-31
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.